Stockreport

Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Clinical data readout expected end of Q3 2024SER-155 and other Seres microbiome therapeutic candidates have potential to expand microbiome therapeutic franchise into add [Read more]